Difference between revisions of "Stub"
m (→FEC & HP) |
|||
| Line 183: | Line 183: | ||
====Radiotherapy==== | ====Radiotherapy==== | ||
*Concurrent [[External_beam_radiotherapy|thoracic radiation therapy]] | *Concurrent [[External_beam_radiotherapy|thoracic radiation therapy]] | ||
| + | |||
| + | ==FAP== | ||
| + | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
| + | |- | ||
| + | |[[#top|back to top]] | ||
| + | |} | ||
| + | FAP: '''<u>F</u>'''luorouracil, '''<u>A</u>'''lfa interferon, '''<u>P</u>'''latinol (Cisplatin) | ||
| + | ===Regimen=== | ||
| + | ====Chemotherapy==== | ||
| + | *[[Fluorouracil (5-FU)]] | ||
| + | *[[Cisplatin (Platinol)]] | ||
| + | ====Immunotherapy==== | ||
| + | *[[Interferon alfa-2b (Intron-A)]] | ||
==FEC & HP== | ==FEC & HP== | ||
Revision as of 02:38, 7 September 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the Ontology.
Abiraterone & Enzalutamide
| back to top |
Regimen
Hormonotherapy
ACP
| back to top |
ACP: Atezolizumab, Carboplatin, Paclitaxel
Regimen
Immunotherapy
Chemotherapy
Afatinib & Vinorelbine
| back to top |
Regimen
Chemotherapy
Targeted therapy
Bortezomib & Bevacizumab
| back to top |
Regimen
Targeted therapy
Bortezomib & Siltuximab
| back to top |
Regimen
Targeted therapy
BTH (Taxotere)
| back to top |
BTH: Bevacizumab, Taxotere (Docetaxel), Herceptin (Trastuzumab)
Regimen
Chemotherapy
Targeted therapy
CAD
| back to top |
CAD: Cyclophosphamide, Adriamycin (Doxorubicin), DDP (Cisplatin)
Regimen
Chemotherapy
Carboplatin & Epirubicin
| back to top |
Regimen
Chemotherapy
Carboplatin & Topotecan
| back to top |
Regimen
Chemotherapy
CE & Ipilimumab
| back to top |
CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab
Regimen
Chemotherapy
Immunotherapy
CE & Thalidomide
| back to top |
CE & Thalidomide: Carboplatin, Etoposide, Thalidomide
Regimen
Chemotherapy
Targeted therapy
Cisplatin & Methotrexate
| back to top |
Regimen
Chemotherapy
Docetaxel & Pertuzumab
| back to top |
Regimen
Chemotherapy
Targeted therapy
Encorafenib monotherapy
| back to top |
Regimen
Targeted therapy
EP & Ipilimumab
| back to top |
EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab
Regimen
Chemotherapy
Immunotherapy
EP, Tamoxifen, RT
| back to top |
EP, GM-CSF, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy
Regimen
Chemotherapy
Hormonotherapy
Radiotherapy
- Concurrent thoracic radiation therapy
FAP
| back to top |
FAP: Fluorouracil, Alfa interferon, Platinol (Cisplatin)
Regimen
Chemotherapy
Immunotherapy
FEC & HP
| back to top |
FEC & HP: Fluorouracil, Epirubicin, Cyclophosphamide, Herceptin (Trastuzumab), Pertuzumab
Regimen
Chemotherapy
Targeted therapy
FULV & Trimetrexate
| back to top |
FULV & Trimetrexate: 5-FU & LeucoVorin (Folinic acid), Trimetrexate
Regimen
Chemotherapy
Ixabepilone & Bevacizumab
| back to top |
Regimen
Chemotherapy
Targeted therapy
MFL
| back to top |
MFL: Methyl-lomustine (MeCCNU), 5-FU & LeucoVorin (Folinic acid)
Regimen
Chemotherapy
Mitoxantrone & Hydrocortisone
| back to top |
Regimen
Chemotherapy
Hormonotherapy
MTP
| back to top |
MTP: Myocet (Non-pegylated liposomal doxorubicin), Trastuzumab, Paclitaxel
Regimen
Chemotherapy
Targeted therapy
PD & Pembrolizumab
| back to top |
PD & Pembrolizumab: Pomalidomide, Dexamethasone, Pembrolizumab
Regimen
Targeted therapy
Immunotherapy
Pixantrone & Rituximab
| back to top |
Regimen
Chemotherapy
Targeted therapy
TCHL (Taxotere)
| back to top |
TCHL: Taxotere (Docetaxel), Carboplatin, Herceptin (Trastuzumab), Lapatinib
Regimen
Chemotherapy
Targeted therapy
TCL (Taxotere)
| back to top |
TCL: Taxotere (Docetaxel), Carboplatin, Lapatinib
Regimen
Chemotherapy
Targeted therapy
TEC
| back to top |
TEC: Taxol (Paclitaxel), Epirubicin, Carboplatin
Regimen
Chemotherapy
TG+Bev
| back to top |
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TH (Taxol) & Everolimus
| back to top |
TH & Everolimus: Taxol (Paclitaxel), Herceptin (Trastuzumab), Everolimus
Regimen
Chemotherapy
Targeted therapy
TL (Taxotere)
| back to top |
TL: Taxotere (Docetaxel) & Lapatinib
Regimen
Chemotherapy
Targeted therapy
TX+Bev
| back to top |
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab
Regimen
Chemotherapy
Targeted therapy
Vinorelbine & Hydrocortisone
| back to top |
Regimen
Chemotherapy
Hormonotherapy
VTDC
| back to top |
VTDC: Velcade (Bortezomib), Thalidomide, Dexamethasone, Cyclophosphamide